Cell Therapy
Gene Therapy
Raw Materials
Strategy
Supply Chain

Reducing Manufacturing Bottlenecks: Nailing Your Process Development and Manufacturing Enhancement Early

Phacilitate
19 May 2022
SHARE NOW

NOW AVAILABLE ON DEMAND

Join global leaders in the development and deployment of cell and gene therapies as they discuss assistive technological advancements, the need for standardization, and the implications on the end-user and patient of the necessary quality, speed and cost modifiers for advanced therapies.

WHAT TO EXPECT

Moderated by Patrick Lucy (Lykan Bioscience), join Tony Ward, (Curate Bioscience), Lior Raviv (Pluristem), Ronit Slotky (Hackensack University Medical Center) and Kelly O’Hare (Lykan Bioscience) for a discussion on:

    • Processes that are designed with the full manufacturing journey in mind:
      • Technologies that enable scale out/scale up
      • Focus on quality
      • Innovative process and analytical solutions streamlining processing and maximizing yield
      • Reduction of COGs
    • Enablement of process visualization, data capture and real-time testing and release in the cGMP environment
    • Considerations for the end-user 

The second part of the session will be reserved for an interactive audience Q&A.

This content is brought to you in partnership with Phacilitate, Lykan Bioscience and Curate Biosciences, who are independent but joint controllers. You may receive follow up communications from Phacilitate, Lykan Bioscience and Curate Biosciences with information directly related to this content, and you will be able to opt out from being contacted by using the unsubscribe links in these emails.

Lykan Bioscience Privacy Policy | Curate Biosciences Privacy Policy